Delivery Order SPE2DB22D3016-SPE2DB25FAUR7
- Not listed
- The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,960.42 firm fixed price delivery order for DARZALEX FASPRO 1,800MG-30,000 15ML, with an ultimate completion date of July 8, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This is a firm fixed-price delivery order valued at $89,703.15, with an ultimate completion date of October 15, 2025. The contract involves no set-aside designation and represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $35,881.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with an ultimate completion date of October 20, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 18, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a single transaction on AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $191,367 for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, is issued under a firm fixed-price structure with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is funded through the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $149,505.25 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price contract, awarded September 26, 2025, with an ultimate completion date of October 20, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a $166,845.06 delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAUR7Delivery Order
The Defense Logistics Agency awarded a $17,940.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO, a pharmaceutical product supplied in 1,800mg-30,000 unit vials. This non-set-aside competitive award, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio supporting federal medical procurement, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen holds a significant $999,999,999.00 IDC vehicle (SPE2DX) with the Defense Logistics Agency running through December 2026, which enables the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 4/24/25 |